Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
AORN Journal
|
January 30, 2014
Boston bombings: response to disaster
Maureen Hemingway, Joanne Ferguson
Pediatric Research
|
August 29, 2020
Defining necrotizing enterocolitis: current difficulties and future opportunities
Ravi Mangal Patel, Joanne Ferguson, Steven J McElroy, et al.
Pediatric Research
|
August 29, 2020
Human milk fortification: the clinician and parent perspectives
Amy B Hair, Joanne Ferguson, Cristal Grogan, et al.
JACC. Cardiovascular Interventions
|
January 15, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials
Dean J Kereiakes, Krishnankutty Sudhir, James B Hermiller, et al.
Journal of the American Society of Nephrology : JASN
|
August 7, 2010
Overexpression of VEGF165b in podocytes reduces glomerular permeability
Yan Qiu, Joanne Ferguson, Sebastian Oltean, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
AORN Journal
|
January 30, 2014
Boston bombings: response to disaster
Maureen Hemingway, Joanne Ferguson
Pediatric Research
|
August 29, 2020
Defining necrotizing enterocolitis: current difficulties and future opportunities
Ravi Mangal Patel, Joanne Ferguson, Steven J McElroy, et al.
Pediatric Research
|
August 29, 2020
Human milk fortification: the clinician and parent perspectives
Amy B Hair, Joanne Ferguson, Cristal Grogan, et al.
JACC. Cardiovascular Interventions
|
January 15, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials
Dean J Kereiakes, Krishnankutty Sudhir, James B Hermiller, et al.
Journal of the American Society of Nephrology : JASN
|
August 7, 2010
Overexpression of VEGF165b in podocytes reduces glomerular permeability
Yan Qiu, Joanne Ferguson, Sebastian Oltean, et al.
Page
of 1